Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Alnylam Pharmace. | 34 | 0 | 3 | 0 | €138.40 | €236.30 | 70.736% |
Neurocrine Bioscience | 21 | 0 | 3 | 0 | €128.00 | €136.69 | 6.791% |
Tenet Healthcare | 21 | 0 | 2 | 0 | €97.00 | €95.79 | -1.243% |
Jazz Pharmaceuticals plc | 20 | 0 | 10 | 0 | €111.60 | €184.14 | 65.000% |
Acadia Pharmaceuticals | 20 | 0 | 3 | 0 | €16.90 | €32.44 | 91.931% |
Iovance Biotherapeutics Inc. | 19 | 3 | 3 | 1 | €13.67 | €22.78 | 66.608% |
Exelixis Inc. | 15 | 0 | 0 | 0 | €21.97 | €26.01 | 18.372% |
United Therapeutics | 15 | 0 | 3 | 0 | €212.80 | €289.92 | 36.241% |
Insulet Corp. | 13 | 0 | 0 | 0 | €158.75 | €215.54 | 35.772% |
Merit Medical Systems | 13 | 0 | 3 | 0 | €69.50 | €86.66 | 24.690% |
Ultragenyx Pharmaceutical Inc. | 13 | 1 | 0 | 0 | €43.40 | €84.74 | 95.263% |
Icon plc | 12 | 0 | 0 | 0 | €311.50 | €319.67 | 2.623% |
Amedisys Inc. | 12 | 0 | 2 | 0 | €84.00 | €92.26 | 9.833% |
Repligen Corp. | 12 | 0 | 0 | 0 | €170.20 | €182.96 | 7.497% |
Halozyme Therapeutics Inc. | 11 | 0 | 0 | 0 | €37.52 | €54.92 | 46.386% |
Arrowhead Pharmaceuticals Inc. | 13 | 2 | 0 | 0 | €26.49 | €49.32 | 86.199% |
Molina Healthcare | 11 | 1 | 0 | 1 | €380.60 | €376.32 | -1.124% |
Bio-Techne Corp. | 9 | 0 | 0 | 0 | €64.50 | €75.80 | 17.519% |
Charles River Labs Intl | 9 | 0 | 0 | 0 | €251.10 | €248.57 | -1.008% |
QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
Alkermes plc | 11 | 2 | 1 | 1 | €24.60 | €33.15 | 34.750% |
Xencor Inc. | 8 | 1 | 0 | 0 | €20.20 | €31.57 | 56.274% |
Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
LivaNova plc | 7 | 0 | 2 | 0 | €49.60 | €65.63 | 32.310% |
MorphoSys AG | 7 | 0 | 0 | 0 | €67.18 | €65.00 | -3.245% |